FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2020/07/026429 [Registered on: 08/07/2020] Trial Registered Prospectively
Last Modified On: 07/07/2020
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Biological 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Therapeutic measures in Sepsis patients. 
Scientific Title of Study   Effect of supplementation of Albumin in patients of Sepsis with hypoalbuminemia. 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Monika G 
Designation  Post graduate doctor 
Affiliation  Maulana Azad Medical College ,New Delhi 
Address  Department of Medicine Maualana Azad Medical College, Bahadur Shah Zafar Marg, New Delhi

Central
DELHI
110002
India 
Phone  9811971751  
Fax    
Email  monicaegk999@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Mradul Kumar Daga 
Designation  Director Professor 
Affiliation  Maulana Azad Medical College, New Delhi 
Address  Department of Medicine Maulana Azad Medical College, Bahadur Shah Zafar Marg, New Delhi

Central
DELHI
110002
India 
Phone  9968604273  
Fax    
Email  drmraduldaga@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Monika G 
Designation  Post graduate Doctor  
Affiliation  Maulana Azad Medical College ,New Delhi 
Address  Department of Medicine Maualana Azad Medical College, Bahadur Shah Zafar Marg, New Delhi

Central
DELHI
110002
India 
Phone  9811971751  
Fax    
Email  monicaegk999@gmail.com  
 
Source of Monetary or Material Support  
Maulana Azad Medical College And Associated Lok Nayak Hospital,Bahadur Shah Zafar Marg,New Delhi-110002 
 
Primary Sponsor  
Name  Maulana Azad Medical College 
Address  Bahadur Shah Zafar Marg,New Delhi,India-110002 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
Dr Mradul Kumar Daga  Department of Medicine,Maulana Azad Medical College and Associated Lok Nayak Hospital, Bahadur Shah Zafar Marg, New Delhi,India-110002 
Dr Sandeep Garg  Department of Medicine,Maulana Azad Medical College and Associated Lok Nayak Hospital, Bahadur Shah Zafar Marg, New Delhi,India-110002 
Dr Smita Kaushik  Department of Biochemistry,Maulana Azad Medical College and Associated Lok Nayak Hospital, Bahadur Shah Zafar Marg, New Delhi,India-110002 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Monika G  Lok Nayak Hospital  Maulana Azad Medical College and Associated Lok Nayak Hospital, Bahadur Shah Zafar Marg, New Delhi,India-110002
Central
DELHI 
9811971751

monicaegk999@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Instituitional Ethics Committee,Maulana Azad Medical College and Associated Lok Nayak Hospital,GIPMER and GNEC,New Delhi-110002  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: R652||Severe sepsis,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Standard treatment of sepsis  Only standard treatment of sepsis given according to latest guidelines 
Intervention  Supplementation of Albumin   Supplementation of albumin in patients of sepsis with hypoalbuminemia 300ml of 20% Albumin solution on first day,then 200ml/day during hospital stay provided their serum albumin concentration is 3.1g/dl 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  99.00 Year(s)
Gender  Both 
Details  Patients of sepsis as per standard criteria laid down in sepsis guidelines 2016(sepsis 3) with hypoalbuminemia 
 
ExclusionCriteria 
Details  Patients with chronic liver disease and chronic kidney disease
Expected length of hospital stay is less then 3 days
Evidence of fluid overload
Patients of burns and trauma
Immunocompromised status
Patients of anaphylaxis and adrenal insufficiency
Malnourishment and malabsorption  
 
Method of Generating Random Sequence   Other 
Method of Concealment   Other 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
Disease outcome-Recovery/mortality   Less than or equal to one year 
 
Secondary Outcome  
Outcome  TimePoints 
Length of Hospital stay

 
Less than or equal to one year 
Duration of antibiotic therapy
 
Less than or equal to one year 
Duration of inotropic support and ventilation
 
Less than or equal to one year 
Transfer to ICU and Length of ICU stay  Less than or equal to one year 
 
Target Sample Size   Total Sample Size="80"
Sample Size from India="80" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   10/07/2020 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Nil 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   Effective, safe pharmacological agents are need of the hour in the management of sepsis.
Aims and objectives:
1. To study the effect of supplementation of albumin in sepsis patients with hypoalbuminemia
2. To study the prognostic value of ratio of CRP/albumin in outcome of sepsis
 
Close